The decrease in EAAT2 expression was also seen in several other neurodegenerative disorders such as AD, Huntington’s disease, and epilepsy, corroborating the causal role of astrocytes to glutamate toxicity [139]. This evidence concerns the gene SLC1A2 and Alzheimer disease.